• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染武汉、阿尔法或德尔塔SARS-CoV-2变体的住院COVID-19幸存者的相关起始症状和COVID-19后症状

Associated-Onset Symptoms and Post-COVID-19 Symptoms in Hospitalized COVID-19 Survivors Infected with Wuhan, Alpha or Delta SARS-CoV-2 Variant.

作者信息

Fernández-de-Las-Peñas César, Cancela-Cilleruelo Ignacio, Rodríguez-Jiménez Jorge, Gómez-Mayordomo Victor, Pellicer-Valero Oscar J, Martín-Guerrero José D, Hernández-Barrera Valentín, Arendt-Nielsen Lars, Torres-Macho Juan

机构信息

Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Universidad Rey Juan Carlos (URJC), 28922 Madrid, Spain.

CNAP, Center for Sensory-Motor Interaction (SMI), Department of Health Science and Technology, Faculty of Medicine, Aalborg University, 9220 Aalborg, Denmark.

出版信息

Pathogens. 2022 Jun 25;11(7):725. doi: 10.3390/pathogens11070725.

DOI:10.3390/pathogens11070725
PMID:35889971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9320021/
Abstract

This study compared associated-symptoms at the acute phase of infection and post-COVID-19 symptoms between individuals hospitalized with the Wuhan, Alpha or Delta SARS-CoV-2 variant. Non-vaccinated individuals hospitalized because of SARS-CoV-2 infection in one hospital during three different waves of the pandemic (Wuhan, Alpha or Delta) were scheduled for a telephone interview. The presence of post-COVID-19 symptoms was systematically assessed. Hospitalization and clinical data were collected from medical records. A total of 201 patients infected with the Wuhan variant, 211 with the Alpha variant and 202 with Delta variant were assessed six months after hospitalization. Patients infected with the Wuhan variant had a greater number of symptoms at hospital admission (higher prevalence of fever, dyspnea or gastrointestinal problems) than those infected with Alpha or Delta variant (p < 0.01). A greater proportion of patients infected with the Delta variant reported headache, anosmia or ageusia as onset symptoms (p < 0.01). The mean number of post-COVID-19 symptoms was higher (p < 0.001) in individuals infected with the Wuhan variant (mean: 2.7 ± 1.3) than in those infected with the Alpha (mean: 1.8 ± 1.1) or Delta (mean: 2.1 ± 1.5) variant. Post-COVID-19 dyspnea was more prevalent (p < 0.001) in people infected with the Wuhan variant, whereas hair loss was higher in those infected with the Delta variant (p = 0.002). No differences in post-COVID-19 fatigue by SARS-CoV-2 variant were found (p = 0.594). Differences in COVID-19 associated onset symptoms and post-COVID-19 dyspnea were observed depending on the SARS-CoV-2 variant. The presence of fatigue was a common post-COVID-19 symptom to all SARS-CoV-2 variants.

摘要

本研究比较了感染武汉株、阿尔法株或德尔塔株严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的住院患者在感染急性期的相关症状以及感染新冠病毒后的症状。在疫情的三个不同阶段(武汉株、阿尔法株或德尔塔株流行期),对一家医院因SARS-CoV-2感染住院的未接种疫苗个体进行电话访谈。系统评估感染新冠病毒后的症状。从病历中收集住院和临床数据。共对201例感染武汉株、211例感染阿尔法株和202例感染德尔塔株的患者在住院6个月后进行评估。感染武汉株的患者入院时症状更多(发热、呼吸困难或胃肠道问题的患病率更高),高于感染阿尔法株或德尔塔株的患者(p<0.01)。感染德尔塔株的患者中,报告头痛、嗅觉丧失或味觉丧失为首发症状的比例更高(p<0.01)。感染武汉株的个体感染新冠病毒后的平均症状数更高(p<0.001)(平均:2.7±1.3),高于感染阿尔法株(平均:1.8±1.1)或德尔塔株(平均:2.1±1.5)的个体。感染新冠病毒后呼吸困难在感染武汉株的人群中更为普遍(p<0.001),而脱发在感染德尔塔株的人群中更高(p=0.002)。未发现不同SARS-CoV-2毒株感染后疲劳情况存在差异(p=0.594)。观察到不同SARS-CoV-2毒株在新冠病毒相关首发症状和感染新冠病毒后呼吸困难方面存在差异。疲劳是所有SARS-CoV-2毒株感染新冠病毒后的常见症状。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8707/9320021/0b7149f68344/pathogens-11-00725-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8707/9320021/bca771023b19/pathogens-11-00725-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8707/9320021/0b7149f68344/pathogens-11-00725-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8707/9320021/bca771023b19/pathogens-11-00725-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8707/9320021/0b7149f68344/pathogens-11-00725-g002.jpg

相似文献

1
Associated-Onset Symptoms and Post-COVID-19 Symptoms in Hospitalized COVID-19 Survivors Infected with Wuhan, Alpha or Delta SARS-CoV-2 Variant.感染武汉、阿尔法或德尔塔SARS-CoV-2变体的住院COVID-19幸存者的相关起始症状和COVID-19后症状
Pathogens. 2022 Jun 25;11(7):725. doi: 10.3390/pathogens11070725.
2
Headache as a COVID-19 onset symptom and post-COVID-19 symptom in hospitalized COVID-19 survivors infected with the Wuhan, Alpha, or Delta SARS-CoV-2 variants.作为 COVID-19 发病症状和 COVID-19 后症状的头痛,在感染武汉、阿尔法或德尔塔 SARS-CoV-2 变异株的住院 COVID-19 幸存者中。
Headache. 2022 Oct;62(9):1148-1152. doi: 10.1111/head.14398. Epub 2022 Sep 16.
3
Prevalence of Musculoskeletal Post-COVID Pain in Hospitalized COVID-19 Survivors Depending on Infection with the Historical, Alpha or Delta SARS-CoV-2 Variant.根据感染历史毒株、阿尔法或德尔塔SARS-CoV-2变体情况,住院COVID-19康复者中肌肉骨骼新冠后疼痛的患病率
Biomedicines. 2022 Aug 11;10(8):1951. doi: 10.3390/biomedicines10081951.
4
Post-COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among Hospitalized vs Nonhospitalized Patients.SARS-CoV-2 感染后 2 年住院与非住院患者的新冠后症状。
JAMA Netw Open. 2022 Nov 1;5(11):e2242106. doi: 10.1001/jamanetworkopen.2022.42106.
5
Post-COVID Syndrome: The Stranger Ghost of Culprit COVID-19.新冠后遗症:元凶新冠的陌生幽灵。
J Assoc Physicians India. 2023 Feb;71(2):11-12. doi: 10.5005/japi-11001-0193.
6
Differences in Long-COVID Symptoms between Vaccinated and Non-Vaccinated (BNT162b2 Vaccine) Hospitalized COVID-19 Survivors Infected with the Delta Variant.接种疫苗与未接种疫苗(BNT162b2疫苗)的感染德尔塔变异株的新冠住院幸存者的长期新冠症状差异。
Vaccines (Basel). 2022 Sep 6;10(9):1481. doi: 10.3390/vaccines10091481.
7
Long-COVID Symptoms in Individuals Infected with Different SARS-CoV-2 Variants of Concern: A Systematic Review of the Literature.不同关注的 SARS-CoV-2 变异株感染个体的长新冠症状:文献系统综述。
Viruses. 2022 Nov 25;14(12):2629. doi: 10.3390/v14122629.
8
Analysis of SARS-CoV-2 isolates, namely the Wuhan strain, Delta variant, and Omicron variant, identifies differential immune profiles.对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)毒株,即武汉毒株、德尔塔变种和奥密克戎变种的分析,确定了不同的免疫特征。
Microbiol Spectr. 2023 Sep 7;11(5):e0125623. doi: 10.1128/spectrum.01256-23.
9
Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.社区人群中与新型冠状病毒感染相关的症状和症状群:一项全州范围流行病学研究的结果
medRxiv. 2020 Oct 22:2020.10.11.20210922. doi: 10.1101/2020.10.11.20210922.
10
Evaluation of post-COVID symptoms of the SARS-CoV-2 Delta and Omicron variants in children: a prospective study.儿童中SARS-CoV-2 Delta和Omicron变体的新冠后症状评估:一项前瞻性研究。
Eur J Pediatr. 2023 Oct;182(10):4565-4571. doi: 10.1007/s00431-023-05134-6. Epub 2023 Aug 1.

引用本文的文献

1
Consensus based recommendations for the management of post-COVID long-term sequelae (Long COVID): a regional perspective.基于共识的新冠后长期后遗症(长新冠)管理建议:区域视角
Front Med (Lausanne). 2025 Aug 6;12:1453167. doi: 10.3389/fmed.2025.1453167. eCollection 2025.
2
Oral Manifestations in the Post COVID-19 Condition: A Systematic Review With Meta-Analysis.新冠疫情后状况下的口腔表现:一项荟萃分析的系统评价
Rev Med Virol. 2025 Jul;35(4):e70057. doi: 10.1002/rmv.70057.
3
Cognitive impairment 2 years after mild to severe SARS-CoV-2 infection in a population-based study with matched-comparison groups.

本文引用的文献

1
Clinical and Virological Characteristics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) B.1.617.2 (Delta) Variant: A Prospective Cohort Study.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)B.1.617.2(德尔塔)变种的临床和病毒学特征:一项前瞻性队列研究
Clin Infect Dis. 2022 Aug 24;75(1):e27-e34. doi: 10.1093/cid/ciac239.
2
Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS).新冠后(post-COVID-19)综合征和慢性疲劳综合征(ME/CFS)患者的血管内皮功能障碍和内皮生物标志物改变。
J Transl Med. 2022 Mar 22;20(1):138. doi: 10.1186/s12967-022-03346-2.
3
一项基于人群并设有匹配对照组的研究中,轻度至重度新冠病毒感染2年后的认知障碍情况。
Sci Rep. 2025 Jul 8;15(1):24335. doi: 10.1038/s41598-025-96608-0.
4
Evolution of long COVID over two years in hospitalised and non-hospitalised survivors in Bangladesh: a longitudinal cohort study.孟加拉国住院和非住院幸存者中长新冠两年的演变:一项纵向队列研究
J Glob Health. 2025 Mar 14;15:04075. doi: 10.7189/jogh.15.04075.
5
Inflammatory discoveries two years after acute severe COVID-19: a longitudinal biomarker profile assessment in long COVID individuals in the Brazilian Amazon.急性重症 COVID-19 两年后的炎症发现:巴西亚马逊地区新冠长期症状患者的纵向生物标志物特征评估
Front Immunol. 2024 Dec 23;15:1520193. doi: 10.3389/fimmu.2024.1520193. eCollection 2024.
6
Unraveling the SARS-CoV-2 spike protein long-term effect on neuro-PASC.揭示严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白对新冠后综合征(PASC)神经系统长期影响的奥秘。
Front Cell Neurosci. 2024 Dec 18;18:1481963. doi: 10.3389/fncel.2024.1481963. eCollection 2024.
7
Dermatological complications due to post‑COVID‑19 syndrome: A systematic review.新冠后综合征导致的皮肤并发症:一项系统综述。
Med Int (Lond). 2024 Nov 26;5(1):9. doi: 10.3892/mi.2024.208. eCollection 2025 Jan-Feb.
8
COVID-19 and persistent symptoms: implications for polycystic ovary syndrome and its management.COVID-19 与持续症状:对多囊卵巢综合征及其管理的影响。
Front Endocrinol (Lausanne). 2024 Oct 4;15:1434331. doi: 10.3389/fendo.2024.1434331. eCollection 2024.
9
Exploring cognitive impairments and the efficacy of phosphatidylcholine and computer-assisted cognitive training in post-acute COVID-19 and post-acute COVID-19 Vaccination Syndrome.探索急性 COVID-19 后及急性 COVID-19 疫苗接种综合征中的认知障碍以及磷脂酰胆碱和计算机辅助认知训练的疗效。
Front Neurol. 2024 Sep 3;15:1419134. doi: 10.3389/fneur.2024.1419134. eCollection 2024.
10
Post-Acute Sequelae and Mitochondrial Aberration in SARS-CoV-2 Infection.新型冠状病毒感染的后遗症和线粒体异常。
Int J Mol Sci. 2024 Aug 21;25(16):9050. doi: 10.3390/ijms25169050.
Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms.
新冠病毒病的长期后遗症:对新冠后症状进行的为期一年随访研究的系统评价和荟萃分析
Pathogens. 2022 Feb 19;11(2):269. doi: 10.3390/pathogens11020269.
4
Emergence of SARS-CoV-2 Variants in the World: How Could This Happen?全球范围内严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体的出现:这是如何发生的?
Life (Basel). 2022 Jan 28;12(2):194. doi: 10.3390/life12020194.
5
Analysis of online search trends suggests that SARS-CoV-2 Omicron (B.1.1.529) variant causes different symptoms.对在线搜索趋势的分析表明,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎(B.1.1.529)变种会引发不同症状。
J Infect. 2022 May;84(5):e76-e77. doi: 10.1016/j.jinf.2022.02.011. Epub 2022 Feb 17.
6
A clinical case definition of post-COVID-19 condition by a Delphi consensus.德尔菲共识对新冠后状况的临床病例定义。
Lancet Infect Dis. 2022 Apr;22(4):e102-e107. doi: 10.1016/S1473-3099(21)00703-9. Epub 2021 Dec 21.
7
Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic.奥密克戎新冠病毒变体:新冠疫情的新篇章。
Lancet. 2021 Dec 11;398(10317):2126-2128. doi: 10.1016/S0140-6736(21)02758-6. Epub 2021 Dec 3.
8
Risk factors and incidence of long-COVID syndrome in hospitalized patients: does remdesivir have a protective effect?住院患者中长新冠综合征的危险因素及发病率:瑞德西韦是否具有保护作用?
QJM. 2022 Jan 9;114(12):865-871. doi: 10.1093/qjmed/hcab297.
9
Viral loads and profile of the patients infected with SARS-CoV-2 Delta, Alpha, or R.1 variants in Tokyo.在东京感染 SARS-CoV-2 Delta、Alpha 或 R.1 变异株的患者的病毒载量和特征。
J Med Virol. 2022 Apr;94(4):1707-1710. doi: 10.1002/jmv.27479. Epub 2021 Dec 2.
10
Global surveillance, research, and collaboration needed to improve understanding and management of long COVID.需要进行全球监测、研究与合作,以增进对新冠长期症状的了解并改善其管理。
Lancet. 2021 Dec 4;398(10316):2057-2059. doi: 10.1016/S0140-6736(21)02444-2. Epub 2021 Nov 10.